FNYS
ELGX

First New York Securities’s Endologix Inc ELGX Stock Holding History

First New York Securities’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-170
Closed -$18K – 585
2014
Q3 		$18K Buy
+170
New +$23.7K 0.01% 349

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First New York Securities's ELGX Position: Q4 2014 in Review

First New York Securities sold out of Endologix Inc (ELGX) in Q4 2014, closing a stake of 170 shares — an estimated $18K sold.

First New York Securities first reported a position in ELGX in Q3 2014 and held it in 1 quarter. The position peaked at $18K in Q3 2014. 122 funds tracked by Wall St. Rank hold ELGX as of Q4 2014.

  • First New York Securities reported no remaining Endologix Inc position as of Q4 2014 after selling out during the quarter.
  • First New York Securities sold 170 Endologix Inc shares in Q4 2014, an estimated $18K.
  • First New York Securities first reported a position in Endologix Inc in Q3 2014 and held it in 1 quarter.
  • First New York Securities's Endologix Inc position peaked at $18K in Q3 2014.
  • 122 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2014.

Based on First New York Securities's 13F filing for Q4 2014, filed 9 Jan 2015.